Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[211At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [211At]astatine

Bioconjugate Chemistry

Volumn 20, Issue 10, 2009, Pages 1983-1991

  Wilbur, D Scott ^a   Thakar, Monica S ^a,c   Hamlin, Donald K ^a   Santos, Erlinda B ^c   Chyan, Ming Kuan ^a   Nakamae, Hirohisa ^c   Pagel, John M ^a,c   Press, Oliver W ^a,b,c   Sandmaier, Brenda M ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTATINE; TISSUE;

BALB/C MICE; CHLORAMINE-T; CLOSO-DECABORATE; IN-VIVO; LABELING METHODS; LABELINGS; POST INJECTION; SULFHYDRYL GROUPS; TISSUE DISTRIBUTIONS; VIVO TISSUE;

MONOCLONAL ANTIBODIES;

ANTIBODY CONJUGATE; ASTATINE 211; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD45 AT 211; MONOCLONAL ANTIBODY CD45 I 125; MONOCLONAL ANTIBODY I 125; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; ISOTOPE LABELING; MOUSE; NONHUMAN;

MUS; RATTUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD45; ASTATINE; BENZOATES; FEMALE; ISOTOPE LABELING; MALEIMIDES; MICE; MICE, INBRED BALB C; RADIOISOTOPES; RATS; SPLEEN; TISSUE DISTRIBUTION;

EID: 70350302359     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9000799     Document Type: Article

References (32)

1. Bethge, W. A., Wilbur, D. S., and Sandmaier, B. M. (2006) Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation. Leuk. Lymphoma 47, 1205-1214 (Pubitemid 44269625)
2. Sandmaier, B. M., Bethge, W. A., Wilbur, D. S., Hamlin, D. K., Santos, E. B., Brechbiel, M. W., Fisher, D. R., and Storb, R. (2002) Bismuth-213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts. Blood 100, 318-326
3. Bethge, W. A., Wilbur, D. S., Storb, R., Hamlin, D. K., Santos, E. B., Brechbiel, M. W., Fisher, D. R., and Sandmaier, B. M. (2003) Selective T-cell ablation with bismuth-213-labeled anti- TCRαβ as nonmyeloablative conditioning for allogeneic canine marrow transplantation. Blood 101, 5068-5075 (Pubitemid 36857775)
4. Bethge, W. A., Wilbur, D. S., Storb, R., Hamlin, D. K., Santos, E. B., Brechbiel, M. W., and Sandmaier, B. M. (2004) Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study. Transplantation 78, 352-359. (Pubitemid 39095400)
5. 211At]astatide and development of labeling reagents to increase stability. Curr. Radiopharm. 1, 144-176.
6. 125I]iodobenzoyl conjugate. Bioconjugate Chem. 2, 171-179
7. Zalutsky, M. R., and Narula, A. S. (1988) Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate. Appl. Radiat. Isot. 39, 227-232.
8. 2 fragments with the α-particle-emitting nuclide astatine-211: Preservation of Immunoreactivity and in vivo localizing capacity. Proc. Natl. Acad. Sci. U.S.A. 86, 7149-7153.
9. 211At labeling of humanized anti-Tac. Nucl. Med. Biol. 28, 845-856.
10. Persson, M. I., Gedda, L., Jensen, H. J., Lundqvist, H., Malmstrom, P. U., and Tolmachev, V. (2006) Astatinated trastuzumab, a putative agent for radionuclide immunotherapy of ErbB2-expressing tumours. Oncol. Rep. 15, 673-680
11. 211At labeling of proteins. Nucl. Med. Biol. 31, 1061-1071.
12. 211At-labeled chimeric antitenascin monoclonal antibody 81C6. J. Nucl. Med. 49, 30-38
13. 2. Nucl. Med. Biol. 20, 917-927
14. Wilbur, D. S., Hamlin, D. K., Chyan, M. K., Kegley, B. B., Quinn, J., and Vessella, R. L. (2004) Biotin reagents in antibody pretargeting. 6. Synthesis and in vivo evaluation of astatinated and radioiodinated aryl- and nido-carboranyl-biotin derivatives. Bioconjugate Chem. 15, 601-616 (Pubitemid 38678546)
15. Wilbur, D. S., Chyan, M. K., Hamlin, D. K., Vessella, R. L., Wedge, T. J., and Hawthorne, M. F. (2007) Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination. Bioconjugate Chem. 18, 1226-1240
16. 211At alpha-particles. J. Nucl. Med. 46, 700-706
17. 211At-astatobenzoate synthesis. J. Nucl. Med. 46, 1393-1400
18. 211At. J. Nucl. Med. 48, 1190-1196
19. Garg, P. K., Archer, G. E., Jr., Bigner, D. D., and Zalutsky, M. R. (1989) Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling. Int. J. Rad. Appl. Instrum. [A] 40, 485-490
20. 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models. Blood 93,737-745
21. Caniatti, M., Roccabianca, P., Scanziani, E., Paltrinieri, S., and Moore, P. F. (1996) Canine lymphoma: immunocytochemical analysis of fine-needle aspiration biopsy. Vet. Pathol. 33, 204-212 (Pubitemid 126484262)
22. Barsoukov, A. A., Moore, P. F., Storb, R., Santos, E. B., and Sandmaier, B. M. (1999) The use of an anti-TCRαβ monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation. Transplantation 67, 1329-1335 (Pubitemid 29252408)
23. Kaplan, H. M., Brewer, N. R., Blair, W. H. (1983) Physiology, In The Mouse in Biomedical Research (Foster, H. L., Small, J. D., and Fox, J. G., Eds.) pp 248-292, Academic Press, New York.
24. Hylarides, M. D., Mallett, R. W., and Meyer, D. L. (2001) A robust method for the preparation and purification of antibody/streptavidin conjugates. Bioconjugate Chem. 12, 421-427.
25. Wilbur, D. S., Hadley, S. W., Grant, L. M., and Hylarides, M. D. (1991) Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab. Bioconjugate Chem. 2, 111-116
26. Nakamae, H., Wilbur, D. S., Hamlin, D. K., Thakar, M. S., Santos, E. B., Fisher, D. R., A. L., K., Pagel, J. M., Press, O. W., Storb, R., and Sandmaier, B. M. (2009) Biodistributions, myelosuppression and toxicities in mice treated with an anti-CD45 antibody labeled with the α-emitting radionuclides bismuth-213 or astatine-211. Cancer Res. 69, 2408-2415.
27. Zalutsky, M. R., and Vaidyanathan, G. (2000) Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy. Curr. Pharm. Des. 6, 1433-1455
28. Wilbur, D. S. (1992) Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjugate Chem. 3, 433-470
29. 2 fragment. Cancer Res. 50, 3514-3520
30. Zalutsky, M. R., Stabin, M. G., Larsen, R. H., and Bigner, D. D. (1997) Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an alpha-particle-emitting immunoconjugate. Nucl. Med. Biol. 24, 255-261
31. 211At-labeled antibodies for clinical use. J. Nucl. Med. 42, 1508-1515
32. 125I-Labelled monoclonal antibodies. Biodistribution in mice carrying human osteosarcoma xenografts. J. Labelled. Compd. Radiopharm. 34, 773-785.